Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IRESSEF (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation) is a prominent private research institution and clinical research organization based in Senegal. Founded by Professor Souleymane Mboup, a co-discoverer of HIV-2, the institute specializes in infectious disease research, epidemiological surveillance, and clinical trial management. IRESSEF operates state-of-the-art laboratory facilities in Diamniadio and Dakar, serving as a regional hub for West Africa in the fight against diseases such as Ebola, HIV, malaria, and tuberculosis. The organization partners with global health entities, pharmaceutical companies, and academic institutions to conduct Phase I through Phase IV clinical trials. Its work is critical in developing and validating diagnostics and vaccines tailored to the needs of populations in the Global South.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut de Recherche en Santé.